Non-Small Cell Lung Cancer, Version 6.2015 Featured Updates to the NCCN Guidelines

被引：322

作者：

Ettinger, David S. ^{[1
]}

Wood, Douglas E. ^{[2
]}

Akerley, Wallace ^{[3
]}

Bazhenova, Lyudmila A. ^{[4
]}

Borghaei, Hossein ^{[5
]}

Camidge, David Ross ^{[6
]}

Cheney, Richard T. ^{[7
]}

Chirieac, Lucian R. ^{[8
]}

D'Amico, Thomas A. ^{[9
]}

Demmy, Todd L. ^{[7
]}

Dilling, Thomas J. ^{[10
]}

Dobelbower, M. Chris ^{[11
]}

Govindan, Ramaswamy ^{[12
,13
]}

Grannis, Frederic W., Jr. ^{[14
]}

Horn, Leora ^{[15
]}

Jahan, Thierry M. ^{[16
]}

Komaki, Ritsuko ^{[17
]}

Krug, Lee M. ^{[18
]}

Lackner, Rudy P. ^{[19
]}

Lanuti, Michael ^{[20
]}

Lilenbaum, Rogerio ^{[21
]}

Lin, Jules ^{[22
]}

Loo, Billy W., Jr. ^{[23
]}

Martins, Renato ^{[24
]}

Otterson, Gregory A. ^{[25
,26
]}

Patel, Jyoti D. ^{[27
]}

Pisters, Katherine M. ^{[17
]}

Reckamp, Karen ^{[14
]}

Riely, Gregory J. ^{[18
]}

Rohren, Eric ^{[17
]}

Schild, Steven E. ^{[28
]}

Shapiro, Theresa A. ^{[1
]}

Swanson, Scott J. ^{[8
]}

Tauer, Kurt ^{[29
]}

Yang, Stephen C. ^{[1
]}

Gregory, Kristina ^{[30
]}

Hughes, Miranda

机构：

[1] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21287 USA

[2] Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA

[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[4] UC San Diego Moores Canc Ctr, San Diego, CA USA

[5] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA

[6] Univ Colorado, Ctr Canc, Boulder, CO 80309 USA

[7] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

[8] Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02115 USA

[9] Duke Canc Inst, Durham, NC 27705 USA

[10] Moffit Canc Ctr, Tampa, FL 33612 USA

[11] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL USA

[12] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO 63110 USA

[13] Washington Univ, Sch Med, St Louis, MO 63130 USA

[14] City Hope Comprehens Canc Ctr, Duarte, CA USA

[15] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[16] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[17] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[18] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[19] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[20] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

[21] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[22] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA

[23] Stanford Canc Inst, Palo Alto, CA USA

[24] Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA USA

[25] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[26] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA

[27] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[28] Mayo Clin, Ctr Canc, Rochester, MN USA

[29] Univ Tennessee, St Jude Childrens Hosp, Hlth Sci Ctr, Knoxville, TN 37996 USA

[30] Natl Comprehens Canc Network, Ft Washington, PA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2015年 / 13卷 / 05期

关键词：

GROWTH-FACTOR-RECEPTOR; TYROSINE KINASE INHIBITORS; ESMO CONSENSUS CONFERENCE; ALK GENE REARRANGEMENT; ACQUIRED-RESISTANCE; EGFR MUTATION; CLINICOPATHOLOGICAL FEATURES; TUMOR SPECIMENS; OPEN-LABEL; CRIZOTINIB;

D O I：

10.6004/jnccn.2015.0071

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

These NCCN Guidelines Insights focus on recent updates to the 2015 NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC). Appropriate targeted therapy is very effective in patients with advanced NSCLC who have specific genetic alterations. Therefore, it is important to test tumor tissue from patients with advanced NSCLC to determine whether they have genetic alterations that make them candidates for specific targeted therapies. These NCCN Guidelines Insights describe the different testing methods currently available for determining whether patients have genetic alterations in the 2 most commonly actionable genetic alterations, notably anaplastic lymphoma kinase (ALK) gene rearrangements and sensitizing epidermal growth factor receptor (EGFR) mutations.

引用

页码：515 / 524

页数：10

共 50 条

[31] Biliary Tract Cancers, Version 2.2023 Featured Updates to the NCCN Guidelines
Benson, Al B., III
D'Angelica, Michael I.
Abrams, Thomas
Abbott, Daniel E.
Ahmed, Aijaz
Anaya, Daniel A.
Anders, Robert
Are, Chandrakanth
Bachini, Melinda
Binder, David
Borad, Mitesh
Bowlus, Christopher
Brown, Daniel
Burgoyne, Adam
Castellanos, Jason
Chahal, Prabhleen
Cloyd, Jordan
Covey, Anne M.
Glazer, Evan S.
Hawkins, William G.
Iyer, Renuka
Jacob, Rojymon
Jennings, Lawrence
Kelley, R. Kate
Kim, Robin
Levine, Matthew
Palta, Manisha
Park, James O.
Raman, Steven
Reddy, Sanjay
Ronnekleiv-Kelly, Sean
Sahai, Vaibhav
Singh, Gagandeep
Stein, Stacey
Turk, Anita
Vauthey, Jean-Nicolas
Venook, Alan P.
Yopp, Adam
McMillian, Nicole
Schonfeld, Ryan
Hochstetler, Cindy
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (07): : 695 - 704
[32] Chronic Myelogenous Leukemia, Version 1.2014 Featured Updates to the NCCN Guidelines
O'Brien, Susan
Radich, Jerald P.
Abboud, Camille N.
Akhtari, Mojtaba
Altman, Jessica K.
Berman, Ellin
DeAngelo, Daniel J.
Deininger, Michael
Devine, Steven
Fathi, Amir T.
Gotlib, Jason
Jagasia, Madan
Kropf, Patricia
Moore, Joseph O.
Pallera, Arnel
Pinilla-Ibarz, Javier
Reddy, Vishnu Vb.
Shah, Neil P.
Smith, B. Douglas
Snyder, David S.
Wetzler, Meir
Gregory, Kristina
Sundar, Hema
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (11): : 1327 - 1340
[33] Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022 Featured Updates to the NCCN Guidelines
Wierda, William G.
Brown, Jennifer
Abramson, Jeremy S.
Awan, Farrukh
Bilgrami, Syed F.
Bociek, Greg
Brander, Danielle
Chanan-Khan, Asher A.
Coutre, Steve E.
Davis, Randall S.
Eradat, Herbert
Fletcher, Christopher D.
Gaballa, Sameh
Ghobadi, Armin
Hamid, Muhammad Saad
Hernandez-Ilizaliturri, Francisco
Hill, Brian
Kaesberg, Paul
Kamdar, Manali
Kaplan, Lawrence D.
Khan, Nadia
Kipps, Thomas J.
Ma, Shuo
Mato, Anthony
Mosse, Claudio
Schuster, Stephen
Siddiqi, Tanya
Stephens, Deborah M.
Ujjani, Chaitra
Wagner-Johnston, Nina
Woyach, Jennifer A.
Ye, J. Christine
Dwyer, Mary A.
Sundar, Hema
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (06): : 622 - 634
[34] Ovarian Cancer/Fallopian Tube Cancer/Primary PeritonealCancer, Version 3.2024Featured Updates to the NCCN Guidelines
Liu, Joyce
Berchuck, Andrew
Backes, Floor J.
Cohen, Joshua
Grisham, Rachel
Leath, Charles A., III
Martin, Lainie
Matei, Daniela
Miller, David S.
Robertson, Sharon
Barroilhet, Lisa
Uppal, Shitanshu
Hendrickson, Andrea Wahner
Gershenson, David M.
Gray, Heidi J.
Hakam, Ardeshir
Jain, Angela
Konecny, Gottfried E.
Moroney, John
Ratner, Elena
Schorge, John
Thaker, Premal H.
Werner, Theresa L.
Zsiros, Emese
Behbakht, Kian
Chen, Lee-May
Derosa, Marie
Eisenhauer, Eric L.
Leiserowitz, Gary
Litkouhi, Babak
Mchale, Michael
Percac-Lima, Sanja
Rodabaugh, Kerry
Vargas, Roberto
Jones, Frankie
Kovach, Emily
Hang, Lisa
Ramakrishnan, Swathi
Alvarez, Ronald D.
Armstrong, Deborah K.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (08): : 512 - 519
[35] Novel therapeutic targets in non-small cell lung cancer
Alamgeer, Muhammad
Ganju, Vinod
Watkins, D. Neil
CURRENT OPINION IN PHARMACOLOGY, 2013, 13 (03) : 394 - 401
[36] Novel agents in development for advanced non-small cell lung cancer
Stinchcombe, Thomas E.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2014, 6 (05) : 240 - 253
[37] Emerging protein kinase inhibitors for non-small cell lung cancer
Liu, Stephen V.
Subramaniam, Deepa
Cyriac, George C.
Abdul-Khalek, Feras J.
Giaccone, Giuseppe
EXPERT OPINION ON EMERGING DRUGS, 2014, 19 (01) : 51 - 65
[38] Molecular profiling of non-small cell lung cancer
Forsythe, Marika L.
Alwithenani, Akram
Bethune, Drew
Castonguay, Mathieu
Drucker, Arik
Flowerdew, Gordon
French, Daniel
Fris, John
Greer, Wenda
Henteleff, Harry
MacNeil, Mary
Marignani, Paola
Morzycki, Wojciech
Plourde, Madeleine
Snow, Stephanie
Xu, Zhaolin
PLOS ONE, 2020, 15 (08):
[39] Non-small cell lung cancer - genetic predictors
Koudelakova, Vladimira
Kneblova, Magdalena
Trojanec, Radek
Drabek, Jiri
Hajduch, Marian
BIOMEDICAL PAPERS-OLOMOUC, 2013, 157 (02): : 125 - 136
[40] The biology and management of non-small cell lung cancer
Herbst, Roy S.
Morgensztern, Daniel
Boshoff, Chris
NATURE, 2018, 553 (7689) : 446 - 454

← 1 2 3 4 5 →